This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kroca, M.
Right arrow Articles by Tärnvik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kroca, M.
Right arrow Articles by Tärnvik, A.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, September 2001, p. 949-954, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.949-954.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Vgamma 9Vdelta 2 T Cells in Human Legionellosis

Michal Kroca,1,2,3 Anders Johansson,1,4 Anders Sjöstedt,4 and Arne Tärnvik1,*

Departments of Infectious Diseases1 and Clinical Bacteriology,4 Umeå University, Umeå University Hospital, SE-901 85 Umeå, and Defense Research Establishment, SE-901 82 Umeå,3 Sweden, and Institute of Radiobiology and Immunology, PMMA, Hradec Kralove, Czech Republic2

Received 26 March 2001/Returned for modification 17 May 2001/Accepted 11 July 2001


    ABSTRACT
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

In humans, expansion of circulating Vgamma 9Vdelta 2 T cells seems to be a pathophysiological denominator shared by protozoan and intracellular bacterial diseases. The assumption was tested here on legionellosis, a condition conforming to the category but not yet described with respect to gamma delta T cells. Levels of Vgamma 9Vdelta 2 T cells in peripheral blood were measured at various intervals in 14 subjects undergoing a Pontiac fever-like disease, shown by serological investigation to be caused by Legionella micdadei. In samples obtained 4 to 6 days after the onset of the disease, the mean percentage (± the standard deviation) of Vgamma 9Vdelta 2+ T cells among CD3+ cells was 1.0% ± 0.5%, compared to 5.0% ± 3.9% in healthy control subjects (P < 0.001). Thereafter, a pronounced increase occurred and at 2 to 7 weeks after onset, mean peak levels were as high as approx 15%. During the next 6 months, values slowly declined, although without reaching the normal range. Percentages of gamma delta + T cells expressing tumor necrosis factor alpha or gamma interferon in response to phorbol myristate acetate were assayed in vitro. At 14 to 16 days after the onset of disease, the expression of both cytokines was increased (P < 0.01), whereas at 5 to 7 weeks, the expression of tumor necrosis factor alpha was decreased (P < 0.05), possibly reflecting modulation of an inflammatory response. In conclusion, Pontiac fever was found to be associated with a pronounced and long-lasting expansion of Vgamma 9Vdelta 2 T cells, implying that the subset may also be pathophysiologically important in a mild and transient form of intracellular bacterial diseases. Surprisingly, the expansion was preceded by a depletion of circulatory Vgamma 9Vdelta 2 T cells. Possibly, Vgamma 9Vdelta 2 T cells are initially recruited to a site of infection before they expand in response to antigen and occur in high numbers in blood.


    INTRODUCTION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Legionella is a genus of gram-negative bacteria and the cause of two different clinical entities. One of them is Legionnaires' disease, a severe pneumonic disease associated with a relatively low attack rate, a long incubation period, and a significant mortality rate (8, 9, 39). Pontiac fever, the other entity, is an acute, influenza-like disease with a brief incubation period, a high attack rate, and a self-limiting course (12, 16). Although both cause a high fever, the difference in clinical expression between the two forms of legionellosis is striking. Due to the transient nature of Pontiac fever, it has even been questioned whether this entity is indeed associated with invasive infection and not a host response to dead bacteria, bacterial toxins, or other bacterial products present in an inhaled aerosol (23, 29). In Legionnaires' disease, as well as Pontiac fever, Legionella pneumophila has been the species most frequently identified. In two reported outbreaks of whirlpool-associated Pontiac fever, however, L. micdadei was implicated as the causative agent (17, 27).

Members of the genus Legionella are facultatively intracellular pathogens, and consequently, the pathogenesis of legionellosis bears similarity to that of tuberculosis, listeriosis, brucellosis, tularemia, and Q fever. The host control of all of these infections depends, to a large extent, on T cells. Like other facultatively intracellular pathogens, Legionella bacteria replicate in mononuclear phagocytes, thereby inducing an alpha beta T-cell-dependent, major histocompatibility complex-restricted immune response to bacterial peptides (20).

Besides alpha beta T cells, 1 to 5% of circulating T cells express the gamma delta T-cell receptor (TCR). Increased levels of gamma delta T cells are found in the circulation of patients with protozoan (19, 33, 35) and intracellular bacterial infections, including mycobacterial disease (21), listeriosis (22), brucellosis (2), tularemia (32, 37), and Q fever (36).

Unlike that of alpha beta T cells, the role of gamma delta T cells in host-parasite interactions is poorly understood. In humans, a sentinel role is ascribed to gamma delta T cells, i.e., a major histocompatibility complex-independent recognition of broadly cross-reactive antigens (6). Cells of one single subset of gamma delta T cells, Vgamma 9Vdelta 2 T cells, account for the increased levels in protozoan and intracellular bacterial diseases. These cells recognize phosphorylated metabolic intermediates, so-called phosphoantigens, which are produced by the causative agents (5, 30, 32, 38).

Like alpha beta T cells, gamma delta T cells are endowed with the ability to produce cytokines. In response to microbial antigens, Vgamma 9Vdelta 2 T cells produce large amounts of tumor necrosis factor alpha (TNF-alpha ) (25) and gamma interferon (IFN-gamma ) (11, 14). Although this would indicate a role primarily in the acute phase of disease, they are also believed to be involved in a later down regulation of the inflammatory response of macrophages in bacterial and viral infections (4). A majority of Vgamma 9Vdelta 2 T cells express CD94, a member of the type C lectin family of killer inhibitory receptor molecules. Signaling through CD94 interferes with the activation of Vgamma 9Vdelta 2 T cells, suggesting a role of the surface receptor in the control of Vgamma 9Vdelta 2 T-cell reactivity (31).

The gamma delta T-cell response seems not to have been studied in legionellosis. When faced with an outbreak of Pontiac fever-like disease, we analyzed levels of Vgamma 9Vdelta 2 T cells in blood. We investigated whether such a transient and mild condition caused by a facultatively intracellular bacterium would indeed induce a Vgamma 9Vdelta 2 T-cell response similar to what had been previously described in more invasive and severe intracellular infections. In the outbreak, comprising 14 cases of Pontiac fever-like disease with a short and well-defined incubation period, we observed an initial decline in Vgamma 9Vdelta 2 T cells in peripheral blood, followed by a dramatic increase and a slow decline over several months, suggesting a dynamic redistribution and expansion of the subset.


    MATERIALS AND METHODS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Subjects. Fourteen patients (six men, eight women; 22 to 57 [median, 46] years old) were included in the study. After spending a weekend at a hotel and visiting a whirlpool facility at the establishment on 16 to 17 April 1999, all patients developed symptoms of disease on 17 to 19 April and were admitted to our hospital on 19 to 22 April. Six patients were hospitalized for a median period of 3 (range, 2 to 4) days, and the others were managed as outpatients. After 14 to 16 days, the patients received a questionnaire to retrospectively determine the duration of the fever, confinement to bed, and symptoms experienced during the illness. Informed consent was obtained from all patients by using a protocol approved by the Committee on Research Ethics at the Medical Faculty, Umeå University, Umeå, Sweden.

A retrospective cohort study suggested that the whirlpool was the source of the outbreak (18).

Two groups of healthy control individuals were included. For measurement of gamma delta and Vgamma 9Vdelta 2 T-cell counts, values from 12 male and 14 female adults (mean age, 39.7 years) were available at the laboratory. These values were quite similar to those previously reported from a previous investigation of a Swedish normal adult population (10). For assay of cytokine production ex vivo, samples from six male and four female adults (mean age, 34.3 years) were obtained concomitantly with patient samples.

Blood chemistry. Blood neutrophil and platelet counts were determined by standard Coulter counter technique on a Sysmex SE-9000 instrument (Toa Medical Electronics Co., Kobe, Japan), and serum C-reactive protein levels were measured with a dry-chemistry enzymatic sandwich immunoassay technique on an Ectachem Instrument (Johnson & Johnson Clinical Diagnostics Inc., Rochester, N.Y.).

Microbiology. By using heat-killed L. pneumophila serogroups 1 to 8, L. bozemanii, L. micdadei, and L. longbeachae serogroups 1 and 2 as antigens, an immunofluorescent immunoglobulin G (IgG) antibody test was performed at the Swedish Institute for Infectious Disease Control, Stockholm, Sweden, as previously described (7). From each patient, serum samples were obtained 2 to 4 days after onset of disease, at days 14 to 16, and at 5 to 6 weeks after onset. In the first sample, all 14 patients showed a titer of serum antibodies to all legionella antigens of <32. In the second or third sample, all 14 patients showed a >= 4-fold increase in the titer of serum antibodies specific to L. micdadei, in three cases to a titer of 64, in six cases to 128, and in the remaining five cases to 256. The titers of all samples toward the remaining 11 legionella antigens were <32 up to 6 weeks after the onset of disease.

In 7 of 14 cases, nasopharyngeal aspirates or swabs that were obtained upon admission to the hospital for culture on selective legionella BCYE and BMP agar (6a) were consistent with no growth. Bacterial culture of blood samples obtained from five patients with febrile disease showed no growth. From each of the 14 patients, two to five urine samples were obtained for assay of L. pneumophila soluble antigen (Biotest AG, Dreieich, Germany), and all were negative. Complement fixation tests of paired serum samples from each of 14 patients showed no antibody response to influenza virus A or B, parainfluenza virus 3, adenovirus, Mycoplasma sp., or Chlamydia psittaci. Enzyme-linked immunosorbent assays of paired samples from 11 patients showed no evidence of hantavirus infection.

MAbs. Monoclonal antibodies (MAbs) to the alpha beta TCR (clone WT31, fluorescein isothiocyanate [FITC] conjugated) and the gamma delta TCR (11F2, FITC and phycoerythrin [PE] conjugated) were purchased from Becton Dickinson, Sunnyvale, Calif. Antibodies to the alpha beta TCR (BMA 031, FITC conjugated) and the gamma delta TCR (5.A6.E9, PE conjugated) were also obtained from Serotec, Oxford, United Kingdom. From this source, CD3 (UCH-T1, PE conjugated), TCR-Vgamma 2 (7A5, FITC conjugated), and TCR-Vdelta 2 (15D, PE conjugated) antibodies were purchased as well. Antibodies to human IFN-gamma (4S.B3, PE conjugated), TNF-alpha (MAb11, PE conjugated), and CD94 (cloneHP-3D9, FITC conjugated) and a mouse IgG1 PE-conjugated isotype control were obtained from Pharmingen, San Diego, Calif. Antibodies to interleukin-4 (clone 8604B312) and a mouse IgG2 isotype control came from Biosource, Fleurus, Belgium. TCR Vgamma 9 (B3, FITC conjugated) and TCR Vdelta 2 (B6, PE conjugated) antibodies were purchased from Pharmingen. Antibodies to CD94 (cloneHP-3D9, FITC conjugated), reacting with the 70-kDa dimer Kp43, were also from Pharmingen.

Flow cytometry analysis of lymphocyte subsets. Surface phenotyping of cells of EDTA-treated blood was performed with conjugated MAbs. Aliquots (50 µl) of blood were incubated with 10 µl of normal mouse serum at a dilution of 1:500 (DAKO, Glostrup, Denmark) for 15 min at room temperature, and 5 µl of appropriate MAbs was added, followed by incubation for 25 min at room temperature. Two milliliters of FACS lysing solution (Becton Dickinson) containing 1% paraformaldehyde was then added to each tube. After 10 min of incubation, cells were washed twice with Cell-Wash solution (Becton Dickinson), resuspended in 500 µl of FACS-flow solution (Becton Dickinson), and stored at 4°C before analysis.

With a FACSort instrument (Becton Dickinson), 10,000 events per sample were recorded. The data were collected and analyzed by use of CellQuest software (Becton Dickinson). Lymphocytes were gated according to their morphologic parameters by means of forward scatter and side scatter analysis or by expression of CD3. Results were expressed as the percentage of CD3 cells stained by a given label.

Analysis of cytokine expression by T cells. For enumeration of cytokine-producing cells, a 100-µl blood sample was diluted with 400 µl of RPMI 1640 medium. Cells were stimulated with 1 ng of phorbol myristate acetate (Sigma, Madison, Wis.) per ml and 1 µM ionomycin (Sigma). Extracellular cytokine transport was blocked by addition of 3 µM monensin (Sigma), and cells were incubated for 4 h at 37°C. This time period was found to be optimal when the technique was standardized for demonstration of TNF-alpha and IFN-gamma expression (28). After stimulation, cells were washed once and stained with conjugated anti-CD3 antibody and anti-TCR alpha beta or anti-TCR gamma delta antibody for 15 min on ice. Erythrocytes were then lysed by addition of 1 ml of FACS lysing solution (Becton Dickinson) for 10 min, washed once, and fixed for 10 min with ice-cold phosphate-buffered saline containing 4% paraformaldehyde and 0.1% saponin (Sigma). Fixed cells were washed once in Cell-Wash solution (Becton Dickinson) containing 0.1% saponin and stained for 15 min on ice with anti-cytokine or isotype control PE-conjugated antibody. Staining was followed by two washes in Cell-Wash solution-saponin and one wash in Cell-Wash solution containing 1% bovine serum albumin. Finally, cells were resuspended in 500 µl of FACS flow solution (Becton Dickinson). Cytokine analysis was performed on CD3-gated cells. Thresholds for cytokine signals were assessed after staining of samples with irrelevant isotype-specific antibodies. Results were expressed as the percentage of cytokine-positive cells in the respective subpopulation. Due to saponin permeabilization, both cytoplasmic and membrane-bound cytokines were detected.

Statistical analysis. For statistical evaluation, the Wilcoxon paired test was used.


    RESULTS
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

Clinical data. All patients presented with fever (maximum, 39.4 to 40.5°C; mean, 39.9°C; n = 14) and influenza-like symptoms. Vital functions were never affected. In three cases, auscultation disclosed discrete pulmonary rales. By radiography, discrete pulmonary infiltrates were found in two of these patients and in a third patient. In one further patient, a small amount of pleural fluid occurred. At follow-up, all chest radiographs were normalized. Macrolides were prescribed for 5 to 10 days in 12 patients, whereas two patients received no antibiotics. The two latter patients did not deviate from the others regarding blood chemistry or gamma delta and Vgamma 9Vdelta 2 T-cell values. According to the patient-completed questionnaire, the most frequent symptoms were myalgia (14), headache (13), arthralgia (12), dizziness (12), fatigue (11), breathing discomfort (7), nausea, vomiting or diarrhea (5), cough (4), and disturbance of short-term memory (3). Defervescence occurred after a median period of 4 days (range, 2 to 7 days; n = 14), and the patients were bedridden for a medium of 5 days (range, 2 to 8 days).

Inflammatory parameters. On admission to the hospital, i.e., 1 to 2 days after the onset of disease, neutrophil counts and levels of C-reactive protein were markedly elevated, compared to normal laboratory values of healthy adults (Fig. 1). Within a few days, both reactants normalized and they remained normal throughout the study period. Relative thrombocytosis was demonstrated later in the course (Fig. 1).


View larger version (14K):
[in this window]
[in a new window]
 
FIG. 1.   Neutrophil counts (normal values, 1.8 × 109 to 6.3 × 109 cells/liter, C-reactive protein levels (normal values, <10 mg/liter) and platelet counts (normal values, 150 × 109 to 350 × 109 cells/liter) at various intervals after onset of Pontiac fever-like disease.

Proportions of gamma delta TCR-expressing T cells at various intervals after onset of disease. From days 4 to 6 to days 14 to 16 after onset of disease, a rise in the proportion of gamma delta T cells was generally observed (Fig. 2). Thereafter, the proportion declined gradually over a 6-month-period. The magnitude of the gamma delta T-cell expansion varied considerably among individuals. This variation was not the result of a day-to-day variation inherent in the assay, because differences among individuals were retained from one sample to another (Fig. 2). Results were similar when expressed as the absolute numbers of gamma delta T cells per microliter of blood (data not shown), indicating that the percentage of gamma delta T cells increased because of expansion and not as a result of a concomitant decrease in the number of alpha beta T cells.


View larger version (27K):
[in this window]
[in a new window]
 
FIG. 2.   Relative numbers of gamma delta + T cells in peripheral blood of patients with legionellosis. Blood samples from 14 patients were obtained at various intervals after onset of legionellosis and analyzed by two-color flow cytometry using anti-gamma delta TCR MAb and anti-CD3 MAb.

When Vgamma 9Vdelta 2 T cells were analyzed separately, these cells were found to account for the changes in gamma delta T-cell percentages (Table 1). Irrespective of the interval, gamma delta T cells other than Vgamma 9Vdelta 2 T cells remained stationary at approx 2% of the total number of CD3+ cells. An unexpected finding was a marked decrease in Vgamma 9Vdelta 2 T cells early after onset. In the first sample, obtained 4 to 6 days after onset, the mean percentage was as low as 1.0% ± 0.5% (Table 1) and significantly (P < 0.001) lower than in control subjects (5.0% ± 3.9%). Thus, an initial reduction and a subsequent dramatic, long-lasting increase in Vgamma 9Vdelta 2 T cells were observed in the peripheral blood of legionellosis patients. At 6 months, values were still significantly (P = 0.001) higher than those of the control group (Table 1).

                              
View this table:
[in this window]
[in a new window]
 
TABLE 1.   Percentages of peripheral blood T cells that were Vgamma 9Vdelta 2 T cells at various intervals after the onset of legionellosis

The majority of circulating Vgamma 9Vdelta 2 T cells express the inhibitory CD94/NKG2-A receptor for HLA class I molecules. The percentage of CD94+ cells of Vgamma 9Vdelta 2 T cells increased significantly (P = 0.01) from days 4 to 6 to the interval of 5 to 7 weeks after onset and normalized at 6 months (Fig. 3).


View larger version (17K):
[in this window]
[in a new window]
 
FIG. 3.   Frequency of CD94+ T cells of Vgamma 9Vdelta 2 T cells at various intervals after onset of legionellosis. The thick line through each box shows the median, with quartiles at either end. The vertical lines indicate maximum and minimum values. *, significantly different (P = 0.01) from the 4- to 6-day interval.

Cytokine expression of gamma delta T cells. At intervals after the onset of disease, cytokine expression by gamma delta T cells in response to short-term stimulation with phorbol myristate acetate and ionomycin was measured in various numbers of patients. On days 14 to 16, the proportions of cells expressing TNF-alpha and/or IFN-gamma were high (Fig. 4). At 5 to 7 weeks, a decrease in cytokine-expressing cells occurred and at this interval, the percentage of TNF-alpha -expressing cells was significantly (P = 0.02) lower than the values of control subjects. In samples obtained at 6 months, the percentages of cells expressing the cytokines were restored (Fig. 4). Irrespective of the time of sampling, only a few percent of the cells expressed interleukin-4 (data not shown).


View larger version (23K):
[in this window]
[in a new window]
 
FIG. 4.   Frequency of cytokine-producing gamma delta + T cells at various intervals after onset of legionellosis. Cytokine analysis was performed on CD3-gated cells double stained with anti-gamma delta antibody and anti-cytokine antibody or an isotype control antibody. The thick line through each box shows the median, with quartiles at either end. The vertical lines indicate maximum and minimum values. *, significantly different from controls at P < 0.05. **, significantly different from controls at P < 0.01.


    DISCUSSION
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

The present outbreak was characterized by a brief incubation period (24 to 48 h) and a transient, influenza-like disease. Neutrophil counts and levels of C-reactive protein increased rapidly and were also quickly normalized. Although pulmonary changes were occasionally found by radiography, they were discrete and symptoms conformed better to Pontiac fever than to Legionnaires' disease. As in two previous outbreaks of whirlpool-associated Pontiac fever in Scotland and Denmark (17, 27), L. micdadei was implicated as the causative agent. In spite of our failure to isolate the causative agent, the consistency of the serological findings on the patient material, together with a uniform clinical expression well in accordance with Pontiac disease, makes the etiology highly likely. It should be added that the specificity of the immunofluorescence test is extremely high (39). Similar to the present experience, attempts to isolate L. micdadei from patients also failed in the two previous outbreaks (17, 27).

All of the changes in gamma delta T cells recorded here refer to the Vgamma 9Vdelta 2 T-cell subset and show a uniform pattern among the patients. An initial decrease was followed by a rapid and prolonged increase. In blood samples obtained 4 to 6 days after onset of disease, the mean percentage of Vgamma 9Vdelta 2 T cells was only 20% of the values of control subjects. Except for this occasion, samples from all patients, as well as control subjects, showed a predominance of Vgamma 9Vdelta 2 cells among gamma 9Vdelta T cells. The simplest explanation for the depletion early after the onset of the disease would be an extravasal migration of the cells into the site of infection, preceding an antigen-induced expansion and reentry into the circulation. It remains to be shown whether the cells accumulate in bronchoalveolar fluid and also whether such an initial depletion of Vgamma 9Vdelta 2 T cells occurs in other intracellular bacterial infections. In experimental Plasmodium falciparum infection, two infected humans showed a transient decrease in Vgamma 9Vdelta 2 T cells in peripheral blood during the second week of infection (34).

The pronounced and protracted increase in Vgamma 9Vdelta 2 T cells, in both absolute numbers and proportions of cells, was similar to that previously recorded in patients with ulceroglandular tularemia, an invasive febrile disease caused by another facultatively intracellular bacterium (24). Such a dramatic and long-standing elevation of Vgamma 9Vdelta 2 T cells in two intracellular bacterial diseases, widely differing in their clinical pictures, supports the assumption that Vgamma 9Vdelta 2 T cells are pathophysiologically important in this kind of infection. No clinical data are available regarding the possible relevance of the long-standing increase in Vgamma 9Vdelta 2 T cells. Increased proportions of the subset have been reported in studies of healthy individuals living in regions with increased exposure to intracellular pathogens (10).

The present results imply that Pontiac fever is due to infection rather than exposure to dead bacteria or bacterial toxins. Several pieces of evidence support this line. In guinea pigs, which are highly susceptible to L. pneumophila, aerogenic exposure to dead organisms of the species caused no signs of disease (1). Moreover, strains of L. pneumophila causing Pontiac fever did not differ from those causing Legionnaires' disease (12), and pneumonic and nonpneumonic forms of legionellosis have been described in patients with a common-source exposure (15). Finally, urine samples from patients with Pontiac fever have shown the presence of Legionella antigen (13).

The function of Vgamma 9Vdelta 2 T cells in host response to intracellular infections remains elusive. In the samples obtained here 14 to 16 days after the onset of legionellosis, a majority of the cells produced TNF-alpha and IFN-gamma after being exposed for 4 h to phorbol myristate acetate. One month later, the cytokine expression capability of the Vgamma 9Vdelta 2 T cells was decreased, TNF-alpha expression in particular. These data may reflect an initial cytokine response important in the activation of bactericidal macrophages, followed by down regulation or modulation of the inflammatory response. A similar change has been observed in tularemia (24). In vitro studies suggest that gamma delta T cells are subjected to a fine-tuned combination of stimulation and inhibition by their interaction with different membrane receptors (26, 31). One of the receptors involved in down regulation is CD94, a type C lectin. In vitro data suggest that CD94 expression is increased on Vgamma 9Vdelta 2 T cells as a result of antigen stimulation (3). We found that its expression increased at 5 to 7 weeks after onset of disease, compared with 4 to 6 days after onset, i.e., concomitantly with the decrease in cytokine expression. In fact, experimental work on intracellular infections has suggested a dual role for gamma delta T cells. After contributing to an early inflammatory response by cytokine expression and activation of macrophages, gamma delta T cells are suggested to participate in termination of the immune response (4).

In conclusion, patients with Pontiac fever-like disease showed an early depletion of Vgamma 9Vdelta 2 T cells from the circulation, followed by a dramatic increase and a subsequent slow decline over the next 6 months. The capability of the cells to express IFN-gamma and TNF-alpha seemed to be down-regulated after the acute phase of the disease. These results support the assumption that Vgamma 9Vdelta 2 T cells are pathophysiologically important in intracellular bacterial infections, including a mild and transient condition such as Pontiac fever.


    ACKNOWLEDGMENTS

Financial support for this study was received from the Swedish Medical Research Council (no. 9485), Västerbottens läns landsting, and the Medical Faculty, Umeå University, Umeå, Sweden.


    FOOTNOTES

* Corresponding author. Mailing address: Department of Infectious Diseases, Umeå University, Umeå University Hospital, SE-901 85 Umeå, Sweden. Phone: 46-90-7852300. Fax: 46-90-133006. E-mail: arne.tarnvik{at}infdis.umu.se.


    REFERENCES
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
References

1. Berendt, R. F., H. W. Young, R. G. Allen, and G. L. Knutsen. 1980. Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila. J. Infect. Dis. 141:186-192[Medline].
2. Bertotto, A., R. Gerli, F. Spinozzi, C. Muscat, F. Scalise, G. Castellucci, M. Sposito, F. Candio, and R. Vaccaro. 1993. Lymphocytes bearing the gamma delta T cell receptor in acute Brucella melitensis infection. Eur. J. Immunol. 23:1177-1180[Medline].
3. Boullier, S., Y. Poquet, F. Halary, M. Bonneville, J.-J. Fournie, and M.-L. Gougeon. 1998. Phosphoantigen activation induces surface translocation of intracellular CD94/NKG2A class I receptor on CD94 - peripheral Vgamma 9 Vdelta 2 T cells but not on CD94 - thymic or mature gamma delta T cell clones. Eur. J. Immunol. 28:3399-3410[CrossRef][Medline].
4. Carding, S. R., and P. J. Egan. 2000. The importance of gamma delta T cells in the resolution of pathogen-induced inflammatory immune responses. Immunol. Rev. 173:98-108[CrossRef][Medline].
5. Constant, P., F. Davodeau, M. A. Peyrat, Y. Poquet, G. Puzo, M. Bonneville, and J.-J. Fournie. 1994. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science 264:267-270[Abstract/Free Full Text].
6. De Libero, G. 1997. Sentinel function of broadly reactive human gamma delta T cells. Immunol. Today 18:22-26[Medline].
6a. Edelstein, P. H. 1985. Legionella, p. 373-381. In E. H. Lenette, A. Balows, W. J. Hausler, Jr., and H. J. Shadomy (ed.), Manual of clinical microbiology, 4th ed. American Society for Microbiology, Washington, D.C.
7. Edelstein, P. H. 1992. Detection of antibodies to Legionella., p. 459-466. In N. R. Rose, E. C. de Macario, J. L. Fahey, H. Friedman, and G. M. Penn (ed.), Manual of clinical laboratory immunology, 4th ed. American Society for Microbiology, Washington, D.C.
8. Edelstein, P. H. 1993. Legionnaires' disease. Clin. Infect. Dis. 16:741-747[Medline].
9. England, A. C., III, D. W. Fraser, B. D. Plikaytis, T. F. Tsai, G. Storch, and C. V. Broome. 1981. Sporadic legionellosis in the United States: the first thousand cases. Ann. Intern. Med. 94:164-170.
10. Esin, S., M. Shigematsu, S. Nagai, A. Eklund, H. Wigzell, and J. Grunewald. 1996. Different percentages of peripheral blood gamma delta + T cells in healthy individuals from different areas of the world. Scand. J. Immunol. 43:593-596[CrossRef][Medline].
11. Follows, G. A., M. E. Munk, A. J. Gatrill, P. Conradt, and S. H. E Kaufmann. 1992. Gamma interferon and interleukin 2, but not interleukin 4, are detectable in gamma /delta T-cell cultures after activation with bacteria. Infect. Immun. 60:1229-1231[Abstract/Free Full Text].
12. Fraser, D. W., D. C. Deubner, D. L. Hill, and D. K. Gilliam. 1979. Nonpneumonic, short-incubation-period legionellosis (Pontiac fever) in men who cleaned a steam turbine condenser. Science 205:690-691[Abstract/Free Full Text].
13. Friedman, S., K. Spitalny, J. Barbaree, Y. Faur, and R. McKinney. 1987. Pontiac fever outbreak associated with a cooling tower. Am. J. Public Health 77:568-572[Abstract/Free Full Text].
14. García, V. E., P. A. Sieling, J. H. Gong, P. F. Barnes, K. Uyemura, Y. Tanaka, B. R. Bloom, C. T. Morita, and R. L. Modlin. 1997. Single-cell analysis of gamma delta T cell responses to nonpeptide mycobacterial antigens. J. Immunol. 159:1328-1335[Abstract].
15. Girod, J. C., R. C. Reichman, W. C. Winn, Jr., D. N. Klaucke, R. L. Vogt, and R. Dolin. 1982. Pneumonic and nonpneumonic forms of legionellosis. The result of a common-source exposure to Legionella pneumophila. Arch. Intern. Med. 142:545-547[Abstract/Free Full Text].
16. Glick, T. H., M. B. Gregg, B. Berman, G. Mallison, W. W. Rhodes, Jr., and I. Kassanoff. 1978. Pontiac fever: an epidemic of unknown etiology in a health department. I. Clinical and epidemiologic aspects. Am. J. Epidemiol. 107:149-160[Abstract/Free Full Text].
17. Goldberg, D. J., J. G. Wrench, P. W. Collier, J. A. Emslie, R. J. Fallon, G. I. Forbes, T. M. McKay, A. C. Macpherson, T. A. Markwick, and D. Reid. 1989. Lochgoilhead fever: outbreak of non-pneumonic legionellosis due to Legionella micdadei. Lancet i:316-318[CrossRef].
18. Götz, H. M., A. Tegnell, B. De Jong, K. A. Broholm, M. Kuusi, I. Kallings, and K. Ekdahl. 2001. A whirlpool associated outbreak of Pontiac fever at a hotel in Northern Sweden. Epidemiol. Infect. 126:241-247[CrossRef][Medline].
19. Ho, M., H. K. Webster, P. Tongtawe, K. Pattanapanyasat, and W. P. Weidanz. 1990. Increased gamma delta T cells in acute Plasmodium falciparum malaria. Immunol. Lett. 25:139-141[CrossRef][Medline].
20. Horwitz, M. A. 1983. Cell-mediated immunity in Legionnaires' disease. J. Clin. Investig. 71:1686-1697.
21. Ito, M., N. Kojiro, T. Ikeda, T. Ito, J. Funada, and T. Kokubu. 1992. Increased proportions of peripheral blood gamma delta T cells in patients with pulmonary tuberculosis. Chest 102:195-197[Abstract/Free Full Text].
22. Jouen-Beades, F., E. Paris, C. Dieulois, J.-F. Lemeland, V. Barre-Dezelus, S. Marret, G. Humbert, J. Leroy, and F. Tron. 1997. In vivo and in vitro activation and expansion of gamma delta T cells during Listeria monocytogenes infection in humans. Infect. Immun. 65:4267-4272[Abstract].
23. Kaufmann, A. F., J. E. McDade, C. M. Patton, J. V. Bennett, P. Skaliy, J. C. Feeley, D. C. Anderson, M. E. Potter, V. F. Newhouse, M. B. Gregg, and P. S. Brachman. 1981. Pontiac fever: isolation of the etiologic agent (Legionella pneumophila) and demonstration of its mode of transmission. Am. J. Epidemiol. 114:337-347[Abstract/Free Full Text].
24. Kroca, M., A. Tärnvik, and A. Sjöstedt. 2000. The proportion of gamma delta T cells increases after the first week of onset of tularaemia and remains elevated for more than a year. Clin. Exp. Immunol. 120:280-284[CrossRef][Medline].
25. Lang, F., M. A. Peyrat, P. Constant, F. Davodeau, J. David-Amelie, Y. Poquet, H. Vié, J. J. Fournié, and M. Bonneville. 1995. Early activation of human Vgamma 9Vdelta 2 T cell broad cytotoxicity and TNF production by nonpeptidic mycobacterial ligands. J. Immunol. 154:5986-5994[Abstract].
26. Lopez-Botet, M., J. J. Perez-Villar, M. Carretero, A. Rodriguez, I. Melero, T. Bellon, M. Llano, and F. Navarro. 1997. Structure and function of the CD94 C-type lectin receptor complex involved in recognition of HLA class I molecules. Immunol. Rev. 155:165-174[CrossRef][Medline].
27. Lüttichau, H. R., C. Vinther, S. A. Uldum, J. Møller, M. Faber, and J. S. Jensen. 1998. An outbreak of Pontiac fever among children following use of a whirlpool. Clin. Infect. Dis. 26:1374-1378[Medline].
28. Mascher, B., P. Schlenke, and M. Seyfarth. 1999. Expression and kinetics of cytokines determined by intracellular staining using flow cytometry. J. Immunol. Methods 223:115-121[CrossRef][Medline].
29. Miller, L. A., J. L. Beebe, J. C. Butler, W. Martin, R. Benson, R. E. Hoffman, and B. S. Fields. 1993. Use of polymerase chain reaction in an epidemiologic investigation of Pontiac fever. J. Infect. Dis. 168:769-772[Medline].
30. Pfeffer, K., B. Schoel, H. Gulle, S. H. E. Kaufmann, and H. Wagner. 1990. Primary responses of human T cells to mycobacteria: a frequent set of gamma /delta T cells are stimulated by protease-resistant ligands. Eur. J. Immunol. 20:1175-1179[Medline].
31. Poccia, F., B. Cipriani, S. Vendetti, V. Colizzi, Y. Poquet, L. Battistini, M. López-Botet, J.-J. Fournié, and M.-L. Gougeon. 1997. CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vgamma 9Vdelta 2 T lymphocytes. J. Immunol. 159:6009-6017[Abstract].
32. Poquet, Y., M. Kroca, F. Halary, S. Stenmark, M.-A. Peyrat, M. Bonneville, J.-J. Fournie, and A. Sjöstedt. 1998. Expansion of Vgamma 9Vdelta 2 T cells is triggered by Francisella tularensis-derived phosphoantigens in tularemia but not after tularemia vaccination. Infect. Immun. 66:2107-2114[Abstract/Free Full Text].
33. Raziuddin, S., A. W. Telmasani, M. El-Hag El-Awad, O. Al-Amari, and M. Al-Janadi. 1992. gamma delta T cells and the immune response in visceral leishmaniasis. Eur. J. Immunol. 22:1143-1148[Medline].
34. Rzepczyk, C. M., S. Stamatiou, K. Anderson, A. Stowers, Q. Cheng, A. Saul, A. Allworth, J. McCormack, M. Whitby, C. Olive, and G. Lawrence. 1996. Experimental human Plasmodium falciparum infections: longitudinal analysis of lymphocyte responses with particular reference to gamma delta T cells. Scand. J. Immunol. 43:219-227[CrossRef][Medline].
35. Scalise, F., R. Gerli, G. Castellucci, F. Spinozzi, G. M. Fabietti, S. Crupi, L. Sensi, R. Britta, R. Vaccaro, and A. Bertotto. 1992. Lymphocytes bearing the gamma delta T-cell receptor in acute toxoplasmosis. Immunology 76:668-670[Medline].
36. Schneider, T., H.-U. Jahn, O. Liesenfeld, D. Steinhoff, E.-O. Riecken, M. Zeitz, and R. Ullrich. 1997. The number and proportion of Vgamma 9Vdelta 2 T cells rise significantly in the peripheral blood of patients after the onset of acute Coxiella burnetii infection. Clin. Infect. Dis. 24:261-264[Medline].
37. Sumida, T., T. Maeda, H. Takahashi, S. Yoshida, F. Yonaha, A. Sakamoto, H. Tomioka, T. Koike, and S. Yoshida. 1992. Predominant expansion of Vgamma 9/Vdelta 2 T cells in a tularemia patient. Infect. Immun. 60:2554-2558[Abstract/Free Full Text].
38. Tanaka, Y., S. Sano, E. Nieves, G. De Libero, D. Rosa, R. L. Modlin, M. B. Brenner, B. R. Bloom, and C. T. Morita. 1994. Nonpeptide ligands for human gamma delta T cells. Proc. Natl. Acad. Sci. USA 91:8175-8179[Abstract/Free Full Text].
39. Winn, W. C., Jr. 1988. Legionnaires disease: historical perspective. Clin. Microbiol. Rev. 1:60-81[Abstract/Free Full Text].


Clinical and Diagnostic Laboratory Immunology, September 2001, p. 949-954, Vol. 8, No. 5
1071-412X/01/$04.00+0   DOI: 10.1128/CDLI.8.5.949-954.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Sicard, H., Ingoure, S., Luciani, B., Serraz, C., Fournie, J.-J., Bonneville, M., Tiollier, J., Romagne, F. (2005). In Vivo Immunomanipulation of V{gamma}9V{delta}2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model. J. Immunol. 175: 5471-5480 [Abstract] [Full Text]  
  • Tarnvik, A., Berglund, L. (2003). Tularaemia. Eur Respir J 21: 361-373 [Abstract] [Full Text]  

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kroca, M.
Right arrow Articles by Tärnvik, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kroca, M.
Right arrow Articles by Tärnvik, A.